These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6113511)

  • 1. Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis.
    Hensen EJ; Claas FH; Vermeer BJ
    Lancet; 1981 Jul; 2(8238):151-2. PubMed ID: 6113511
    [No Abstract]   [Full Text] [Related]  

  • 2. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced toxic epidermal necrolysis.
    Heng MC
    Br J Dermatol; 1985 Nov; 113(5):597-600. PubMed ID: 4063192
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis.
    Stein KM; Schlappner OL; Heaton CL; Decherd JW
    Br J Dermatol; 1972 Mar; 86(3):246-52. PubMed ID: 4553158
    [No Abstract]   [Full Text] [Related]  

  • 5. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis.
    Ammann AJ; Tooley WH; Hong R
    Lancet; 1972 Sep; 2(7775):484-5. PubMed ID: 4115367
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic Epidermal Necrolysis in a Pediatric Patient.
    Hagen S; Grey K; Hylwa S
    Minn Med; 2016; 99(3):49-50. PubMed ID: 27323526
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
    Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
    Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid.
    Iemoli E; Piconi S; Ardizzone S; Bianchi Porro G; Raimond F
    Inflamm Bowel Dis; 2006 Oct; 12(10):1007-8. PubMed ID: 17012974
    [No Abstract]   [Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Eginli A; Shah K; Watkins C; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis and treatment of toxic epidermal necrolysis].
    Hensen E
    Tijdschr Ziekenverpl; 1981 Jun; 34(13):563-7. PubMed ID: 6115482
    [No Abstract]   [Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
    Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
    Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.
    Dumas M; Hua C; Hotz C; Velter C; Duong TA; Maraffi T; Ortonne N; Hüe S; Fardet L; de Prost N; Wolkenstein P; Ingen-Housz-Oro S; Chosidow O
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e360-e361. PubMed ID: 29524279
    [No Abstract]   [Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clues to pathogenesis of toxic epidermal necrolysis.
    Merot Y; Saurat JH
    Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by Fexofenadine.
    Teo SL; Santosa A; Bigliardi PL
    J Investig Allergol Clin Immunol; 2017 Jun; 27(3):191-193. PubMed ID: 28570227
    [No Abstract]   [Full Text] [Related]  

  • 20. Graft-versus-host reaction and toxic epidermal necrolysis.
    Peck GL; Elias PM; Graw RG
    Lancet; 1972 Nov; 2(7787):1151-3. PubMed ID: 4117232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.